ROCHE AMPLICOR QUANTITATIVE HIV TEST APPROVAL FOR PATIENT MONITORING RECOMMENDED BY FDA ADVISORY PANEL; PMA SUPPLEMENT BASED ON AIDS DRUG STUDY
This article was originally published in The Gray Sheet
Executive SummaryRoche Molecular Systems' Amplicor HIV-1 Monitor test kit should be approved as an aid in managing patients receiving anti-viral therapy for HIV infection, FDA's Blood Products Advisory Committee unanimously concluded at a Dec. 12 meeting in Rockville, Maryland.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.